Literature DB >> 22410186

Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.

X Li1, H Wang, H Jing, Y Wang, C Yu, J Wang, Z Liu, E A Graviss, X Ma.   

Abstract

To investigate the prevalence of extensively drug-resistant tuberculosis (XDR-TB) in Chinese populations, we analyzed the drug resistance profiles of 1787 Mycobacterium tuberculosis isolates through a population-based surveillance project in Shandong Province, China. We found 330 (18.5%; 95%CI 16.1-20.3) isolates resistant to ≥1 first-line drug and 65 (3.6%; 95%CI 2.9-4.6) multidrug-resistant (MDR) isolates, of which 13 (20.0%; 95%CI 11.9-31.4) were XDR; 47/65 MDR-TB isolates (70.8%; 95%CI 58.2-81.4) were resistant to fluoroquinolones. Our results indicate that inadequate application of second-line anti-tuberculosis drugs has caused increased prevalence of XDR-TB in certain Chinese populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22410186     DOI: 10.5588/ijtld.11.0507

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Mycobacterium tuberculosis in Saudi Arabia.

Authors:  Bright Varghese; Sahal Al-Hajoj
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

2.  Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.

Authors:  Yi Hu; Sven Hoffner; Linlin Wu; Qi Zhao; Weili Jiang; Biao Xu
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

3.  Rates and risk factors for drug resistance tuberculosis in Northeastern China.

Authors:  Qiao Liu; Limei Zhu; Yan Shao; Honghuan Song; Guoli Li; Yang Zhou; Jinyan Shi; Chongqiao Zhong; Cheng Chen; Wei Lu
Journal:  BMC Public Health       Date:  2013-12-13       Impact factor: 3.295

4.  Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China.

Authors:  H M Adnan Hameed; Yaoju Tan; Md Mahmudul Islam; Lingmin Guo; Chiranjibi Chhotaray; Shuai Wang; Zhiyong Liu; Yamin Gao; Shouyong Tan; Wing Wai Yew; Nanshan Zhong; Jianxiong Liu; Tianyu Zhang
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

5.  Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation.

Authors:  Shenjie Tang; Shouyong Tan; Lan Yao; Fujian Li; Li Li; Xinzhi Guo; Yidian Liu; Xiaohui Hao; Yanqiong Li; Xiuxiu Ding; Zhanjun Zhang; Li Tong; Jianan Huang
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

6.  Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.

Authors:  Hoa Binh Nguyen; Nhung Viet Nguyen; Huong Thi Giang Tran; Hai Viet Nguyen; Quyen Thi Tu Bui
Journal:  Western Pac Surveill Response J       Date:  2016-06-08

7.  Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan.

Authors:  Irfan Ullah; Arshad Javaid; Zarfishan Tahir; Obaid Ullah; Aamer Ali Shah; Fariha Hasan; Najma Ayub
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

Review 8.  Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis.

Authors:  Dandan Li; Tiansheng Wang; Su Shen; Sheng Cheng; Junxian Yu; Yang Zhang; Chao Zhang; Huilin Tang
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.